Collection

Behcet Disease

Since its first description in 1937, Behçet’s syndrome (BS) represents a dilemma both for clinicians and researchers. However, many steps forward the comprehension of the main pathogenetic pathways involved in the development of BS have been done. In addition, the management of this complex neutrophilic vasculitis has been improved, and now an increasing number of different drugs are available for its treatment. Given the broad spectrum of manifestations, the interest for BS involves many different specialists (dermatologist, ophthalmologist, neurologist, and rheumatologist). In addition, internists must be aware of this condition, and take BS into account for the differential diagnosis of specific clinical settings. This collection is focussed on the pathogenetic mechanisms, the main clinical phenotypes and specific treatments have been dedicated to Behcet's syndrome.

Editors

  • Giacomo Emmi

    Prof. Giacomo Emmi is a clinical immunologist, associate Professor of Internal Medicine at the University Hospital Careggi. He is also responsible for the clinical sub-network Autoimmune Diseases of the Tuscan Network of Rare Diseases and deputy director of the School of Specialization in Internal Medicine at the University of Florence (Italy)

Articles (18 in this collection)